Open Access<p>Monitoring and Management of the Patient with Stargardt Disease</p>
Author(s) -
Maria Vittoria Cicinelli,
Marco Battista,
Vincenzo Starace,
Maurizio Battaglia Parodi,
Francesco Bandello
Publication year - 2019
Publication title -
clinical optometry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.421
H-Index - 7
ISSN - 1179-2752
DOI - 10.2147/opto.s226595
Subject(s) - stargardt disease , disease , disease monitoring , modalities , medicine , pathology , ophthalmology , macular degeneration , social science , sociology
Stargardt disease (STGD1) represents one of the major common causes of inherited irreversible visual loss. Due to its high phenotypic and genotypic heterogeneity, STGD1 is a complex disease to understand. Non-invasive imaging, biochemical, and genetic advances have led to substantial improvements in unveiling the disease processes and novel promising therapeutic landscapes have been proposed. This review recapitulates the modalities for monitoring patients with STGD1 and the therapeutic options currently under investigation for the different stages of the disease.